Koers HedgePath Pharmaceuticals Inc
Aandelen
US42278K1025
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13-12-22 |
James McNulty
DFI | Director of Finance/CFO | 73 | 13-12-22 |
Amy M. McCord
LAW | General Counsel | - | 01-01-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13-12-22 |
Samuel Sears
BRD | Director/Board Member | 80 | 02-08-13 |
Ronald Osman
BRD | Director/Board Member | 78 | 23-08-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,16% | 54,04 mld. | |
+46,00% | 41,96 mld. | |
-2,00% | 41,92 mld. | |
-7,20% | 28,35 mld. | |
+11,70% | 26,35 mld. | |
-21,64% | 19 mld. | |
+5,53% | 13 mld. | |
+29,12% | 12,28 mld. | |
+25,34% | 12,19 mld. |